French beauty giant L’Oréal is reportedly in advanced negotiations to acquire a majority stake in Innovist, the Gurugram-based direct-to-consumer (D2C) personal care company behind brands like Bare Anatomy and Vinci Botanicals. The deal, valued at approximately Rs 4,000 crore, could mark one of the largest strategic buyouts in India’s beauty and personal care sector.
Industry insiders confirm that discussions have been ongoing for nearly a year, with talks now entering the final stages. If finalized, the acquisition would strengthen L’Oréal’s foothold in India, a market where the company has acknowledged slower-than-expected growth amid intensifying competition from domestic and global players.
Strategic Expansion In India
L’Oréal’s interest in Innovist reflects its broader strategy to tap into India’s booming D2C beauty ecosystem. Innovist has rapidly scaled its digital-first model, appealing to younger consumers with personalized and science-backed products. The acquisition would allow L’Oréal to integrate Innovist’s agile, consumer-centric approach into its global portfolio.
Market Impact And Valuation
The potential Rs 4,000 crore deal highlights the growing importance of India’s consumer startup ecosystem. Analysts suggest that Innovist’s strong revenue growth and brand recognition make it a valuable asset for L’Oréal, which seeks to rejuvenate its India operations and compete more effectively in the fast-evolving beauty market.
Key Highlights
-
L’Oréal in advanced talks for majority stake in Innovist
-
Deal estimated at Rs 4,000 crore (USD 350–450 million)
-
Innovist owns Bare Anatomy and Vinci Botanicals
-
Negotiations ongoing for nearly a year, now in final phase
-
Acquisition aimed at boosting L’Oréal’s India growth strategy
Sources: ET Retail, BW Businessworld, TechStory